Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Gabriel L Forbes"'
Publikováno v:
Blood Advances, Vol 3, Iss 15, Pp 2312-2316 (2019)
Externí odkaz:
https://doaj.org/article/493e4c8117cd49b182cd54dccb0c5521
Publikováno v:
Blood Advances. 3:2312-2316
Key Points Ponatinib therapy heightens arterial thrombosis and platelet reactivity. Concurrent pioglitazone treatment reverses heightened thrombosis risk and platelet reactivity induced by ponatinib.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::580d0a6d129a8d25986b29e61aea4e58
https://doi.org/10.1182/bloodadvances.2019000034
https://doi.org/10.1182/bloodadvances.2019000034
Autor:
Ravi Kumar Alluri, Matthew Godwin, Gabriel L Forbes, Aatira Vijay, Suman Kundu, Shadi Swaidani, Alvin H. Schmaier, Scott J Cameron, Keith R. McCrae
Publikováno v:
Blood. 138:2083-2083
Introduction Antiphospholipid syndrome (APS) is an autoimmune disorder caused by "antiphospholipid" antibodies (aPL) directed against β2-glycoprotein I (β2GPI). Although β2GPI is proposed to have both anti- and procoagulant properties in vitro, it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::777bbeceeb5add10ccb73a0eb0c876aa
https://doi.org/10.1182/blood-2021-149755
https://doi.org/10.1182/blood-2021-149755
Autor:
Steven C. Mitchell, Peng Zeng, Alvin H. Schmaier, Evi X. Stavrou, Gabriel L Forbes, E.R. Chan, Alona Merkulova
Publikováno v:
Thrombosis Research. 200:S6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b37a06b52485a69a6fca4c33bcd9cfc5
https://doi.org/10.1016/s0049-3848(21)00148-1
https://doi.org/10.1016/s0049-3848(21)00148-1
Publikováno v:
Blood. 134:2423-2423
Introduction: Antiphospholipid syndrome (APS) is an autoimmune disorder caused by "antiphospholipid" antibodies (aPL) directed in part against β2-glycoprotein I (β2GPI). Though β2GPI is proposed to have numerous anti- and procoagulant properties i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8977257a32d23d9739c6df0a4257d380
https://doi.org/10.1182/blood-2019-130521
https://doi.org/10.1182/blood-2019-130521